These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND AFP, AFPD, FETA, HPAFP
209 results:

  • 1. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
    Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
    [No Abstract]    [Full Text] [Related]  

  • 2. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 3. Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer.
    Ren G; Zheng G; Du K; Dang Z; Dan H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F
    Clin Transl Oncol; 2024 Aug; 26(8):2047-2059. PubMed ID: 38453817
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch-repair deficiency.
    Makino K; Ishii T; Takeda H; Saito Y; Fujiwara Y; Fujimoto M; Ito T; Wakama S; Kumagai K; Munekage F; Horie H; Tomofuji K; Oshima Y; Uebayashi EY; Kawai T; Ogiso S; Fukumitsu K; Takai A; Seno H; Hatano E
    J Pathol; 2024 May; 263(1):32-46. PubMed ID: 38362598
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Liver transplantation for treatment of nonresectable primary and secondary liver malignancies : Hepatocellular and cholangiocellular carcinomas and colorectal liver metastases].
    Guba M; Werner J
    Chirurgie (Heidelb); 2024 Apr; 95(4):268-273. PubMed ID: 38329517
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases.
    Peng K; Li Y; Su H; Lan C; Huang Z; Wei Y; Liao X; Peng M; Peng T; Zhu G
    Front Immunol; 2023; 14():1325445. PubMed ID: 38173715
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Blood Biomarkers Panels for Screening of colorectal cancer and Adenoma on a Machine Learning-Assisted Detection Platform.
    Wang H; Zhou Z; Li H; Xiang W; Lan Y; Dou X; Zhang X
    Cancer Control; 2023; 30():10732748231222109. PubMed ID: 38146088
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic value of normal levels of preoperative tumor markers in colorectal cancer.
    Ren G; Li R; Zheng G; Du K; Dan H; Wu H; Dou X; Duan L; Xie Z; Niu L; Tian Y; Zheng J; Feng F
    Sci Rep; 2023 Dec; 13(1):22830. PubMed ID: 38129505
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A sensitive and robust plasma-based DNA methylation panel for early detection of target gastrointestinal cancers.
    Dai Y; Li H; Wu Q; Wang J; Wang K; Fei S; Pei B; Song L; Chen G; Ma Y; Xia C; Xiong S; Zheng M; Xue Y; Zhao G; Xu H
    Neoplasia; 2023 Dec; 46():100941. PubMed ID: 37918207
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinicopathological features of rectal adenocarcinoma with enteroblastic differentiation].
    Liu J; Liu XL; Lin DL; Zhao H; Li YJ; Xing XM
    Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):797-801. PubMed ID: 37527983
    [No Abstract]    [Full Text] [Related]  

  • 11. Correlation between Stool DNA-based SDC2 Methylation Tests Combined with Tumor Markers with Pathological Features in colorectal cancer.
    Cheng Z; Wang Y; Wei W; Liu Y; Zhou Z
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436377
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The role of heavy metals in the development of colorectal cancer.
    Li Y; Lou J; Hong S; Hou D; Lv Y; Guo Z; Wang K; Xu Y; Zhai Y; Liu H
    BMC Cancer; 2023 Jul; 23(1):616. PubMed ID: 37400750
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation.
    Wang Y; Wei X; Ke B; Liu J; Guo Y; Liu Y; Chen Y; Ding T; Wang Y; Meng B; Sun B; Zang F
    Histopathology; 2023 Oct; 83(4):631-646. PubMed ID: 37356975
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Integrated microbiome and metabolome analysis reveals the interaction between intestinal flora and serum metabolites as potential biomarkers in hepatocellular carcinoma patients.
    Li X; Yi Y; Wu T; Chen N; Gu X; Xiang L; Jiang Z; Li J; Jin H
    Front Cell Infect Microbiol; 2023; 13():1170748. PubMed ID: 37260707
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Single-cell characteristics and malignancy regulation of alpha-fetoprotein-producing gastric cancer.
    Mei Y; Li M; Wen J; Kong X; Li J
    Cancer Med; 2023 May; 12(10):12018-12033. PubMed ID: 37017469
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Long-term results of liver thermal ablation in patients with hepatocellular carcinoma and colorectal cancer liver metastasis regarding spatial features and tumor-specific variables.
    Akhan O; Erdemir AG; Karahan S; Ünal E; Çiftçi TT; Akıncı D; Yalçın Ş
    Diagn Interv Radiol; 2024 May; 30(3):183-192. PubMed ID: 36994643
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics.
    Li M; Mei YX; Wen JH; Jiao YR; Pan QR; Kong XX; Li J
    Cancer Lett; 2023 Apr; 559():216104. PubMed ID: 36863507
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Establishment of matrix metalloproteinase 3 time-resolved immunoassay and some potential clinical applications.
    Fu Y; Wang X; Chen X; Hong J; Qin Y; Zhou Z; Zhou X; Wang Y; Zhou J; Fang H; Liu P; Huang B
    Anal Biochem; 2023 Apr; 666():115072. PubMed ID: 36738873
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Sequential Treatment with Activin and Hepatocyte Growth Factor Induces FOXM1 to Promote colorectal cancer Liver Metastasis.
    Peng H; Ye T; Deng L; Yang X; Jiang Z; Guo J
    Can J Gastroenterol Hepatol; 2022; 2022():8996203. PubMed ID: 36591565
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical Value of PET.CT Based on Big Data in colorectal and Peritoneal Metastatic cancer.
    Xiang L; Yang C; Liu W; Li D; Jiang Z; Zhou H
    Contrast Media Mol Imaging; 2022; 2022():6120337. PubMed ID: 36262991
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.